Skip Header

Contribute Send feedback
Read comments (0) or add your own

Reviewed, UniProtKB/Swiss-Prot Q92614 (MY18A_HUMAN)

Last modified January 19, 2010. Version 99. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (5) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Binary interactions · Alternative products · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Myosin-XVIIIa
Alternative name(s):
    Myosin containing a PDZ domain
    Molecule associated with JAK3 N-terminus
      Short name=MAJN
Gene names
Name: MYO18A
Synonyms: KIAA0216, MYSPDZ
OrganismHomo sapiens (Human) [Complete proteome]
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length2054 AA.
Sequence statusComplete.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

May be involved in the maintenance of the stromal cell architectures required for cell to cell contact By similarity.

Subunit structure

Homodimer. Interacts with JAK3 and actin. Ref.5 Ref.7

Subcellular location

Isoform 1: Endoplasmic reticulum-Golgi intermediate compartment By similarity. Cytoplasmcytoskeleton. Note: Colocalizes with actin. Ref.7

Isoform 2: Cytoplasm. Note: Lacks the PDZ domain. Diffusely localized in the cytoplasm. Ref.7

Sequence similarities

Contains 1 IQ domain.

Contains 1 myosin head-like domain.

Contains 1 PDZ (DHR) domain.

Caution

The TIAF1 protein is coded in the 3'-UTR region of MYO18A.

Binary interactions

With

Entry

#Exp.

IntAct

Notes

itself1EBI-949059,EBI-949059

Alternative products

This entry describes 5 isoforms produced by alternative splicing. [Align] [Select]
Isoform 1 (identifier: Q92614-1)

Also known as: Alpha;

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
Note: Colocalizes with actin. Ref.7
Isoform 2 (identifier: Q92614-2)

Also known as: Beta;

The sequence of this isoform differs from the canonical sequence as follows:
     1-331: Missing.
     332-333: SD → MR
Note: Lacks the PDZ domain. Diffusely localized in the cytoplasm. Ref.7
Isoform 3 (identifier: Q92614-3)

The sequence of this isoform differs from the canonical sequence as follows:
     1571-1607: Missing.
     1952-1966: Missing.
Note: No experimental confirmation available.
Isoform 4 (identifier: Q92614-4)

The sequence of this isoform differs from the canonical sequence as follows:
     1952-1966: Missing.
Note: No experimental confirmation available.
Isoform 5 (identifier: Q92614-5)

The sequence of this isoform differs from the canonical sequence as follows:
     1-458: Missing.
     1952-1966: Missing.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 20542054Myosin-XVIIIa
PRO_0000123476

Regions

Domain220 – 31192PDZ
Domain420 – 1186767Myosin head-like
Domain1188 – 121730IQ
Nucleotide binding498 – 5058ATP Potential
Coiled coil1246 – 1971726 Potential
Motif114 – 1185Interaction with actin

Amino acid modifications

Modified residue721Phosphoserine By similarity
Modified residue741Phosphoserine By similarity
Modified residue831Phosphoserine By similarity
Modified residue1021Phosphoserine By similarity
Modified residue1401Phosphoserine Ref.9
Modified residue1641Phosphoserine By similarity
Modified residue2341Phosphoserine Ref.9
Modified residue10391Phosphoserine Ref.10
Modified residue10631Phosphoserine Ref.10
Modified residue10671Phosphoserine Ref.12 Ref.13
Modified residue10701Phosphoserine Ref.13
Modified residue19421Phosphoserine Ref.9 Ref.13
Modified residue19511Phosphoserine Ref.13
Modified residue19701Phosphoserine Ref.9 Ref.13 Ref.14
Modified residue19741Phosphoserine Ref.9 Ref.13 Ref.14
Modified residue19981Phosphoserine Ref.13
Modified residue20021Phosphoserine Ref.13
Modified residue20071Phosphoserine Ref.13
Modified residue20201Phosphoserine Ref.9 Ref.13
Modified residue20361Phosphoserine By similarity
Modified residue20411Phosphoserine Ref.13 Ref.8 Ref.11 Ref.16
Modified residue20431Phosphoserine Ref.13 Ref.8 Ref.11 Ref.16
Modified residue20451Phosphothreonine Ref.13

Natural variations

Alternative sequence1 – 458458Missing in isoform 5.
VSP_023058
Alternative sequence1 – 331331Missing in isoform 2.
VSP_007869
Alternative sequence332 – 3332SD → MR in isoform 2.
VSP_007870
Alternative sequence1571 – 160737Missing in isoform 3.
VSP_007871
Alternative sequence1952 – 196615Missing in isoform 3, isoform 4 and isoform 5.
VSP_007872
Natural variant9581A → V: dbSNP rs8076604. Ref.2 Ref.4
VAR_030585

Experimental info

Mutagenesis114 – 1152RG → AA: No effect on interaction with actin. Ref.7
Mutagenesis117 – 1182VL → AA: Abolishes interaction with actin. Ref.7
Sequence conflict10141A → V in BAD66838. Ref.1
Sequence conflict10201S → P in CAI45931. Ref.3
Sequence conflict17571E → K in CAI45931. Ref.3
Sequence conflict18891E → G in CAI45931. Ref.3

Sequences

Sequence LengthMass (Da)Tools
Isoform 1 (Alpha) [UniParc].

Last modified July 25, 2003. Version 3.
Checksum: 52BFA0AA273E18F7

FASTA2,054233,115
        10         20         30         40         50         60 
MFNLMKKDKD KDGGRKEKKE KKEKKERMSA AELRSLEEMS LRRGFFNLNR SSKRESKTRL 

        70         80         90        100        110        120 
EISNPIPIKV ASGSDLHLTD IDSDSNRGSV ILDSGHLSTA SSSDDLKGEE GSFRGSVLQR 

       130        140        150        160        170        180 
AAKFGSLAKQ NSQMIVKRFS FSQRSRDESA SETSTPSEHS AAPSPQVEVR TLEGQLVQHP 

       190        200        210        220        230        240 
GPGIPRPGHR SRAPELVTKK FPVDLRLPPV VPLPPPTLRE LELQRRPTGD FGFSLRRTTM 

       250        260        270        280        290        300 
LDRGPEGQAC RRVVHFAEPG AGTKDLALGL VPGDRLVEIN GHNVESKSRD EIVEMIRQSG 

       310        320        330        340        350        360 
DSVRLKVQPI PELSELSRSW LRSGEGPRRE PSDAKTEEQI AAEEAWNETE KVWLVHRDGF 

       370        380        390        400        410        420 
SLASQLKSEE LNLPEGKVRV KLDHDGAILD VDEDDVEKAN APSCDRLEDL ASLVYLNESS 

       430        440        450        460        470        480 
VLHTLRQRYG ASLLHTYAGP SLLVLGPRGA PAVYSEKVMH MFKGCRREDM APHIYAVAQT 

       490        500        510        520        530        540 
AYRAMLMSRQ DQSIILLGSS GSGKTTSCQH LVQYLATIAG ISGNKVFSVE KWQALYTLLE 

       550        560        570        580        590        600 
AFGNSPTIIN GNATRFSQIL SLDFDQAGQV ASASIQTMLL EKLRVARRPA SEATFNVFYY 

       610        620        630        640        650        660 
LLACGDGTLR TELHLNHLAE NNVFGIVPLA KPEEKQKAAQ QFSKLQAAMK VLGISPDEQK 

       670        680        690        700        710        720 
ACWFILAAIY HLGAAGATKE AAEAGRKQFA RHEWAQKAAY LLGCSLEELS SAIFKHQHKG 

       730        740        750        760        770        780 
GTLQRSTSFR QGPEESGLGD GTGPKLSALE CLEGMAAGLY SELFTLLVSL VNRALKSSQH 

       790        800        810        820        830        840 
SLCSMMIVDT PGFQNPEQGG SARGASFEEL CHNYTQDRLQ RLFHERTFVQ ELERYKEENI 

       850        860        870        880        890        900 
ELAFDDLEPP TDDSVAAVDQ ASHQSLVRSL ARTDEARGLL WLLEEEALVP GASEDTLLER 

       910        920        930        940        950        960 
LFSYYGPQEG DKKGQSPLLH SSKPHHFLLG HSHGTNWVEY NVTGWLNYTK QNPATQNAPR 

       970        980        990       1000       1010       1020 
LLQDSQKKII SNLFLGRAGS ATVLSGSIAG LEGGSQLALR RATSMRKTFT TGMAAVKKKS 

      1030       1040       1050       1060       1070       1080 
LCIQMKLQVD ALIDTIKKSK LHFVHCFLPV AEGWAGEPRS ASSRRVSSSS ELDLPSGDHC 

      1090       1100       1110       1120       1130       1140 
EAGLLQLDVP LLRTQLRGSR LLDAMRMYRQ GYPDHMVFSE FRRRFDVLAP HLTKKHGRNY 

      1150       1160       1170       1180       1190       1200 
IVVDERRAVE ELLECLDLEK SSCCMGLSRV FFRAGTLARL EEQRDEQTSR NLTLFQAACR 

      1210       1220       1230       1240       1250       1260 
GYLARQHFKK RKIQDLAIRC VQKNIKKNKG VKDWPWWKLF TTVRPLIEVQ LSEEQIRNKD 

      1270       1280       1290       1300       1310       1320 
EEIQQLRSKL EKAEKERNEL RLNSDRLESR ISELTSELTD ERNTGESASQ LLDAETAERL 

      1330       1340       1350       1360       1370       1380 
RAEKEMKELQ TQYDALKKQM EVMEMEVMEA RLIRAAEING EVDDDDAGGE WRLKYERAVR 

      1390       1400       1410       1420       1430       1440 
EVDFTKKRLQ QEFEDKLEVE QQNKRQLERR LGDLQADSEE SQRALQQLKK KCQRLTAELQ 

      1450       1460       1470       1480       1490       1500 
DTKLHLEGQQ VRNHELEKKQ RRFDSELSQA HEEAQREKLQ REKLQREKDM LLAEAFSLKQ 

      1510       1520       1530       1540       1550       1560 
QLEEKDMDIA GFTQKVVSLE AELQDISSQE SKDEASLAKV KKQLRDLEAK VKDQEEELDE 

      1570       1580       1590       1600       1610       1620 
QAGTIQMLEQ AKLRLEMEME RMRQTHSKEM ESRDEEVEEA RQSCQKKLKQ MEVQLEEEYE 

      1630       1640       1650       1660       1670       1680 
DKQKVLREKR ELEGKLATLS DQVNRRDFES EKRLRKDLKR TKALLADAQL MLDHLKNSAP 

      1690       1700       1710       1720       1730       1740 
SKREIAQLKN QLEESEFTCA AAVKARKAME VEIEDLHLQI DDIAKAKTAL EEQLSRLQRE 

      1750       1760       1770       1780       1790       1800 
KNEIQNRLEE DQEDMNELMK KHKAAVAQAS RDLAQINDLQ AQLEEANKEK QELQEKLQAL 

      1810       1820       1830       1840       1850       1860 
QSQVEFLEQS MVDKSLVSRQ EAKIRELETR LEFERTQVKR LESLASRLKE NMEKLTEERD 

      1870       1880       1890       1900       1910       1920 
QRIAAENREK EQNKRLQRQL RDTKEEMGEL ARKEAEASRK KHELEMDLES LEAANQSLQA 

      1930       1940       1950       1960       1970       1980 
DLKLAFKRIG DLQAAIEDEM ESDENEDLIN SLQDMVTKYQ KRKNKLEGDS DVDSELEDRV 

      1990       2000       2010       2020       2030       2040 
DGVKSWLSKN KGPSKAASDD GSLKSSSPTS YWKSLAPDRS DDEHDPLDNT SRPRYSHSYL 

      2050 
SDSDTEAKLT ETNA 

« Hide

Isoform 2 (Beta).

Checksum: A0764A2A6D54D6EC
Show »

FASTA1,723196,438
Isoform 3.

Checksum: 89350E07C2CF8B03
Show »

FASTA2,002226,690
Isoform 4.

Checksum: 70DDB5F30E54B9C3
Show »

FASTA2,039231,240
Isoform 5.

Checksum: DDE7EF34D1A7E515
Show »

FASTA1,581180,495

References

« Hide 'large scale' references
[1]"Alternative splice variants encoding unstable protein domains exist in the human brain."
Homma K., Kikuno R.F., Nagase T., Ohara O., Nishikawa K.
J. Mol. Biol. 343:1207-1220(2004) [PubMed: 15491607] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), NUCLEOTIDE SEQUENCE [MRNA] OF 9-2054 (ISOFORM 1).
Tissue: Brain.
[2]"Prediction of the coding sequences of unidentified human genes. VI. The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by analysis of cDNA clones from cell line KG-1 and brain."
Nagase T., Seki N., Ishikawa K., Ohira M., Kawarabayasi Y., Ohara O., Tanaka A., Kotani H., Miyajima N., Nomura N.
DNA Res. 3:321-329(1996) [PubMed: 9039502] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), VARIANT VAL-958.
Tissue: Brain.
[3]"The full-ORF clone resource of the German cDNA consortium."
Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I.
BMC Genomics 8:399-399(2007) [PubMed: 17974005] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
Tissue: Amygdala.
[4]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), VARIANT VAL-958.
Tissue: Testis.
[5]"A novel protein MAJN binds to Jak3 and inhibits apoptosis induced by IL-2 deprival."
Ji H., Zhai Q., Zhu J., Yan M., Sun L., Liu X., Zheng Z.
Biochem. Biophys. Res. Commun. 270:267-271(2000) [PubMed: 10733938] [Abstract]
Cited for: INTERACTION WITH JAK3.
[6]"Genome structure and differential expression of two isoforms of a novel PDZ-containing myosin (MysPDZ) (Myo18A)."
Mori K., Furusawa T., Okubo T., Inoue T., Ikawa S., Yanai N., Mori K.J., Obinata M.
J. Biochem. 133:405-413(2003) [PubMed: 12761286] [Abstract]
Cited for: ALTERNATIVE SPLICING (ISOFORMS 1 AND 2).
[7]"The N-terminal domain of MYO18A has an ATP-insensitive actin-binding site."
Isogawa Y., Kon T., Inoue T., Ohkura R., Yamakawa H., Ohara O., Sutoh K.
Biochemistry 44:6190-6196(2005) [PubMed: 15835906] [Abstract]
Cited for: SUBCELLULAR LOCATION, HOMODIMERIZATION, INTERACTION WITH ACTIN, MUTAGENESIS OF 114-ARG-GLY-115 AND 117-VAL-LEU-118.
[8]"Global phosphoproteome of HT-29 human colon adenocarcinoma cells."
Kim J.-E., Tannenbaum S.R., White F.M.
J. Proteome Res. 4:1339-1346(2005) [PubMed: 16083285] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2041 AND SER-2043, MASS SPECTROMETRY.
[9]"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks."
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.
Cell 127:635-648(2006) [PubMed: 17081983] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140; SER-234; SER-1942; SER-1970; SER-1974 AND SER-2020, MASS SPECTROMETRY.
Tissue: Epithelium.
[10]"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.
Anal. Sci. 24:161-166(2008) [PubMed: 18187866] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1039 AND SER-1063, MASS SPECTROMETRY.
[11]"Phosphoproteome of resting human platelets."
Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A.
J. Proteome Res. 7:526-534(2008) [PubMed: 18088087] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2041 AND SER-2043, MASS SPECTROMETRY.
Tissue: Platelet.
[12]"Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis."
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III
J. Proteome Res. 7:1346-1351(2008) [PubMed: 18220336] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1067, MASS SPECTROMETRY.
[13]"A quantitative atlas of mitotic phosphorylation."
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P.
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1067; SER-1070; SER-1942; SER-1951; SER-1970; SER-1974; SER-1998; SER-2002; SER-2007; SER-2020; SER-2041; SER-2043 AND THR-2045, MASS SPECTROMETRY.
[14]"Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography."
Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D., Zou H., Gu J.
Proteomics 8:1346-1361(2008) [PubMed: 18318008] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1970 AND SER-1974, MASS SPECTROMETRY.
Tissue: Liver.
[15]Colinge J., Superti-Furga G., Bennett K.L.
Submitted (OCT-2008) to UniProtKB
Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY.
[16]"Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K.
Sci. Signal. 2:RA46-RA46(2009) [PubMed: 19690332] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2041 AND SER-2043, MASS SPECTROMETRY.
Tissue: T-cell.
+Additional computationally mapped references.

Cross-references

Sequence databases

EMBL
GenBank
DDBJ
AB177858 mRNA. Translation: BAD66836.1.
AB177860 mRNA. Translation: BAD66838.1. Different initiation.
D86970 mRNA. Translation: BAA13206.2. Different initiation.
CR933614 mRNA. Translation: CAI45931.1.
BC039612 mRNA. Translation: AAH39612.1.
IPIIPI00334410.
IPI00760846.
IPI00760925.
IPI00827840.
IPI00828082.
RefSeqNP_510880.2.
NP_976063.1.

3D structure databases

SMRQ92614. Positions 217-309, 342-1214.
ModBaseSearch...

Protein-protein interaction databases

IntActQ92614. 8 interactions.
STRINGQ92614.

PTM databases

PhosphoSiteQ92614.

Proteomic databases

PRIDEQ92614.

Genome annotation databases

EnsemblENST00000354329; ENSP00000346291; ENSG00000196535; Homo sapiens. [Genome view]
GeneID399687.
KEGGhsa:399687.
UCSCuc002hds.1. human.
uc002hdt.1. human.
uc002hdu.1. human.
uc010csa.1. human.

Organism-specific databases

CTD399687.
GeneCardsGC17M024425.
H-InvDBHIX0013671.
HGNCHGNC:31104. MYO18A.
HPAHPA019646.
HPA021121.
MIM609517. gene.
610067. gene.
PharmGKBPA134978348.
HUGESearch...
GenAtlasSearch...

Phylogenomic databases

HOGENOMHBG402832.
HOVERGENQ92614.
InParanoidQ92614.
OMALFHERTF.
PhylomeDBQ92614.

Gene expression databases

ArrayExpressQ92614.
BgeeQ92614.
CleanExHS_MYO18A.
GenevestigatorQ92614.
GermOnlineENSG00000196535. Homo sapiens.

Family and domain databases

InterProIPR000048. IQ_CaM_bd_region.
IPR001609. Myosin_head_motor_dom.
IPR002928. Myosin_tail.
IPR001478. PDZ/DHR/GLGF.
IPR020587. RecA_monomer-monomer_interface.
[Graphical view]
PfamPF00063. Myosin_head. 2 hits.
PF01576. Myosin_tail_1. 1 hit.
PF00595. PDZ. 1 hit.
[Graphical view]
PRINTSPR00193. MYOSINHEAVY.
SMARTSM00015. IQ. 1 hit.
SM00242. MYSc. 1 hit.
SM00228. PDZ. 1 hit.
[Graphical view]
PROSITEPS50096. IQ. 1 hit.
PS50106. PDZ. 1 hit.
[Graphical view]
ProtoNetSearch...

Other Resources

NextBio105494.
SOURCESearch...

Entry information

Entry nameMY18A_HUMAN
AccessionPrimary (citable) accession number: Q92614
Secondary accession number(s): Q5H9U3 expand/collapse secondary AC list , Q5W9F9, Q5W9G1, Q8IXP8
Entry history
Integrated into UniProtKB/Swiss-Prot: July 25, 2003
Last sequence update: July 25, 2003
Last modified: January 19, 2010
This is version 99 of the entry and version 3 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation projectHPI (Human Proteome Initiative)
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Relevant documents

Human chromosome 17

Human chromosome 17: entries, gene names and cross-references to MIM

Human entries with polymorphisms or disease mutations

List of human entries with polymorphisms or disease mutations

Human polymorphisms and disease mutations

Index of human polymorphisms and disease mutations

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

SIMILARITY comments

Index of protein domains and families

Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Binary interactions · Alternative products · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents